首页> 外文OA文献 >Lead Screening for HIV-1 Integrase (IN) Inhibited by Traditional Chinese Medicine
【2h】

Lead Screening for HIV-1 Integrase (IN) Inhibited by Traditional Chinese Medicine

机译:通过中药抑制的HIV-1整合酶(IN)的铅筛选

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human immunodeficiency virus causes the acquired immunodeficiency syndrome (AIDS) and becomes a serious world-wide problem because of this disease's rapid propagation and incurability. Integrase strand transfer inhibitors (INSTIs) supports HIV have rapid drug resistance for antitreatment. Screening the traditional Chinese medicine (TCM) database by simulating molecular docking and molecular dynamics may select molecular compounds to inhibit INSTIs against HIV drug resistance. (S)-cathinone and (1S,2S)-norpseudoephedrine are selected based on structure and ligand-based drugs are designed and then get higher bioactivity predicted score from SVM than Raltegravir and other TCM compounds. The molecular dynamics are helpful in the analysis and detection of protein-ligand interactions. According to the docking poses, hydrophobic interactions and hydrogen bond variations define the main regions of important amino acids in integrase. In addition to the detection of TCM compound efficacy, we suggest (1S,2S)-norpseudoephedrine is better than the others based on the analysis of interaction and the effect on the structural variation.
机译:人类免疫缺陷病毒导致获得的免疫缺陷综合症(艾滋病),并且由于这种疾病的快速传播和可生理而成为一个严重的全世界问题。整合酶链转移抑制剂(Instis)支持HIV对抗酸体具有快速的耐药性。通过模拟分子对接和分子动力学来筛选中药(TCM)数据库可以选择分子化合物以抑制抵抗HIV耐药性的inclis。 (s) - 基于结构和配体的药物选择肠甘酮和(1S,2S)-Norpseudoephedrine被设计,然后从SVM和其他TCM化合物获得更高的生物活性预测得分。分子动力学有助于分析和检测蛋白质 - 配体相互作用。根据对接姿势,疏水相互作用和氢键变化在整体酶中限定了重要氨基酸的主要区域。除了检测中医复合功效外,我们建议(1S,2S) - 基于相互作用分析和对结构变异的影响,对外,对外的比例优于其他小吃。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号